Role of endothelin 1 in the pathogenesis of chronic chagasic heart disease

Infection and Immunity

Volumn 73, Issue 4, 2005, Pages 2496-2503

  Tanowitz, Herbert B ^a   Huang, Huan ^a   Jelicks, Linda A ^a   Chandra, Madhulika ^a   Loredo, Maria L ^d   Weiss, Louis M ^a   Factor, Stephen M ^a   Shtutin, Vitaliy ^a   Mukherjee, Shankar ^a   Kitsis, Richard N ^a   Christ, George J ^c   Wittner, Murray ^a   Shirani, Jamshid ^a   Kisanuki, Yaz Y ^b   Yanagisawa, Masashi ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENDOTHELIUM CELL; GENE DELETION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; INFLAMMATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; SURVIVAL; TRYPANOSOMA CRUZI; ANIMAL; C3H MOUSE; C57BL MOUSE; CHRONIC DISEASE; GENETICS; MORTALITY; PARASITEMIA; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CHAGAS CARDIOMYOPATHY; CHRONIC DISEASE; ECHOCARDIOGRAPHY; ENDOTHELIN-1; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; PARASITEMIA;

EID: 20144387330     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.4.2496-2503.2005     Document Type: Article

References (62)

1. Busk, P. K., J. Bartkova, C. C. Strom, L. Wulf-Andersen, R. Hinrichsen, T. E. Christoffersen, L. Latella, J. Bartek, S. Haunso, and S. P. Sheikh. 2002. Involvement of cyclin D1 in left ventricle hypertrophy in vivo and in vitro. Cardiovasc. Res. 56:64-75.
2. A endothelin receptors during the acute phase of Trypanosoma cruzi infection in rats. Microbes Infect. 6:650-656.
3. Chandra, M., H. B. Tanowitz, S. B. Petkova, H. Huang, L. M. Weiss, M. Wittner, S. M. Factor, V. Shtutin, L. A. Jelicks, J. Chan, and J. Shirani. 2002. Significance of inducible nitric oxide synthase in acute myocarditis caused by Trypanosoma cruzi (Tulahuen strain). Int. J. Parasitol. 32:897-905.
4. Chandra, M., J. Shirani, V. Shtutin, L. M. Weiss, S. M. Factor, S. B. Petkova, M. Rojkind, J. A. Dominguez-Rosales, L. A. Jelicks, M. Wittner, and H. B. Tanowitz. 2002. Cardioprotective effects of Verapamil on myocardial structure and function in a murine model of chronic Trypanosoma cruzi infection (Brazil strain): an echocardiographic study. Int. J. Parasitol. 32:207-215.
5. Chandraseka, B., P. C. Melby, D. A. Troyer, J. T. Coloston, and G. L. Freeman. 1998. Temporal expression of pro-inflammatory cytokines and inducible nitric oxide synthase in experimental acute chagasic cardiomyopathy. Am. J. Pathol. 152:925-934.
6. Clouthier, D. E., K. Hosoda, J. A. Richardson, S. C. Williams, H. Yanagisawa, T. Kuwaki, M. Kumada, R. E. Hammer, and M. Yanagisawa. 1998. Cranial and cardiac neural crest defects in endothelin-A receptor deficient mice. Development 125:813-824.
7. Douglas, S. A., L. M. Vickery-Clark, B. L. Storer, T. Hart, C. Louden, J. D. Elliot, and E. H. Oblstein. 1994. A role for endogenous endothelin-1 in neointima formation following rat carotid artery balloon angioplasty: anti-proliferative effects of the non-peptide endothelin receptor antagonist SB209670. Circ. Res. 75:190-197.
8. Goto, K. 2001. Basic and therapeutic relevance of endothelin-mediated regulation. Biol. Pharm. Bull. 24:1219-1230.
9. Guarda, E., P. R. Myers, C. G. Brilla, S. C. Tyugi, and K. T. Weber. 1993. Effects of endothelin on collagen turnover in cardiac fibroblasts. Cardiovasc. Res. 27:213-2134.
10. Hosoda, K., R. E. Hammer, J. A. Richardson, A. G. Baynash, J. C. Cheung, A. Giaid, and M. Yanagisawa. 1994. Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell 79:1267-1276.
11. Huang, H., T. M. Calderon, J. W. Berman, V. L. Braunstein, L. M. Weiss, M. Wittner, and H. B. Tanowitz. 1999. Infection of endothelial cells with Trypanosoma cruzi activates NF-κB and induces vascular adhesion molecule expression. Infect. Immun. 67:5434-5440.
12. Huang, H., J. Chan, M. Wittner, L. A. Jelicks, S. A. Morris, S. M. Factor, L. M. Weiss, V. L. Braunstein, C. J. Bacchi, N. Yarlett, M. Chandra, J. Shirani, and H. B. Tanowitz. 1999. Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice. J. Mol. Cell. Cardiol. 31:75-88.
13. Huang, H., S. B. Petkova, A. W. Cohen, B. Bouzahzah, J. Chan, J. N. Zhou, S. M. Factor, L. M. Weiss, M. Krishnamachary, S. Mukherjee, M. Wittner, R. N. Kitsis, R. G. Pestell, M. P. Lisanti, C. Albanese, and H. B. Tanowitz. 2003. Activation of transcription factors AP-1 and NF-κB in murine Chagasic myocarditis. Infect. Immun. 71:2859-2867.
14. 2-terminal kinase pathway. Circulation 109:904-910.
15. Jelicks, L. A., M. Chandra, J. Shirani, V. Shtuiin, B. Tang, G. J. Christ, S. M. Factor, M. Wittner, H. Huang, L. M. Weiss, S. Mukherjee, B. Bouzahzah, S. B. Petkova, M. M. Teixeira, S. A. Douglas, M. L. Loredo, P. D'Orleans-Juste, and H. B. Tanowitz. 2002. Cardioprotective effects of phosphoramidon on myocardial structure and function in murine Chagas' disease. Int. J. Parasitol. 32:1497-1506.
16. Jelicks, L. A., J. Shirani, M. Wittner, M. Chandra, L. M. Weiss, S. M. Factor, I. Bekirov, V. B. Braunstein, J. Chan, H. Huang, and H. B. Tanowitz. 1999. Application of cardiac gated magnetic resonance imaging in murine Chagas' disease. Am. J. Trop. Med. Hyg. 61:207-214.
17. Katwa, L. 2003. Cardiac myofibroblasts isolated from the site of myocardial infarction express endothelin de nova. Am. J. Physiol. Heart Circ. Physiol. 285:H1132-H1139.
18. Kedzierski, R. M., P. A. Grayburn, Y. Y. Kisanuki, C. S. Williams, R. E. Hammer, J.AS. Richardson, M. D. Schneider, and M. Yanagisawa. 2003. Cardiac myocytes specific endothelin A receptor knockout mice have normal cardiac function and an unaltered hypertrophic response to angiotensin II and isoproterenol. Mol. Cell. Biol. 23:8226-8232.
19. Kedzierski, R. M., and M. Yanagisawa. 2001. Endothelin system: the double-edged sword in health and disease. Annu. Rev. Pharmacol. Toxicol. 41:851-876.
20. Kelly, R., T. L. Hursey, G. L. Schaer, M. S. Piotrowski, S. V. Dee, J. E. Parrillo, and S. M. Hollenberg. 1996. Cardiac endothelin release and infarct size, myocardial blood flow, and ventricular function in canine infarction and reperfusion. J. Investig. Med. 44:575-582.
21. Kirchhoff, L. V., L. M. Weiss, M. Wittner, and H. B. Tanowitz. 2004. Parasitic diseases of the heart. Front. Biosci. 9:706-723.
22. Kisanuki, Y. Y., R. E. Hammer, J. Miyazaki, S. C. Williams, J. A. Richardson, and M. Yanagisawa. 2001. Tie2-cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev. Biol. 230:230-242.
23. Krum, H., R. Denver, A. Tzanidis, and P. Martin. 2001. Diagnostic and therapeutic potential of the endothelin system in patients with chronic heart failure. Heart Failure Rev. 6:341-352.
24. Kurihara, Y., H. Kurihara, H. Oda, K. Maemura, R. Nagai, T. Ishikawa, and Y. Yazaki. 1995. Aortic arch malformation and ventricular septal defects in mice deficient in endothelin 1. J. Clin. Investig. 96:293-300.
25. Kurihara, Y., H. Kurihara, H. Suzuki, T. Kodama, K. Maemura, R. Nagai, H. Oda, T. Kuwaki, W.-H. Cao, N. Kamada, K. Jishage, Y. Ouchi, S. Azuma, Y. Toyoda, T. Ishikawa, M. Kumada, and Y. Yazaki. 1994. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368:703-710.
26. Leon, J. S., and D. M. Engman. 2003. The significance of autoimmunity in the pathogenesis of Chagas heart disease. Front. Biosci. 8:e315-e322.
27. McMurray, J. J., S. G. Ray, I. Abdullah, H. J. Dargie, and J. J. Morton. 1992. Plasma endothelin in chronic heart failure. Circulation 85:1374-1379.
28. Morris, S. A., J. P. Bilezikian, V. Hatcher, P. Gordon, L. M. Weiss, H. B. Tanowitz, and M. Wittner. 1989. Trypanosoma cruzi: infection of cultured human endothelial cells alters inositol phosphate synthesis. Exp. Parasitol. 69:330-339.
29. Morris, S. A., V. Hatcher, J. P. Bilezikian, H. B. Tanowitz, and M. Wittner. 1988. Alterations in intracellular calcium following infection of human endothelial cells with Trypanosoma cruzi. Mol. Biochem. Parasitol. 29:213-221.
30. Morris, S. A., H. B. Tanowitz, M. Makman, V. Hatcher, J. P. Bilezikian, and M. Wittner. 1992. Trypanosoma cruzi: infection of human umbilical vein endothelial cells alter cAMP metabolism. Exp. Parasitol. 74:69-76.
31. Mukherjee, S., H. Huang, L. M. Weiss, S. Costa, J. Scharfstein, and H. B. Tanowitz. 2003. 2003. Role of vasoactive mediators in the pathogenesis of Chagas' disease. Front. Biosci. 8:E410-E419.
32. Mukherjee, S., H. Huang, S. B. Petkova, C. Albanese, R. G. Pestell, V. L. Braunstein, G. J. Christ, M. Wittner, M. P. Lisanti, J. W. Berman, L. M. Weiss, and H. B. Tanowitz. 2004. Trypanosoma cruzi infection activates extracellular signal-regulated kinase in cultured endothelial and smooth muscle cells. Infect. Immun. 72:5274-5282.
33. Mulder, P., V. Richard, G. Derumeaux, M. Hoggie, J. P. Henry, F. Lallemand, P. Compagnon, E. Mace Comoy, B. Letac, and C. Thuillez. 1997. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling. Circulation 96:1976-1982.
34. Petersen, C. A., and B. A. Burleigh. 2003. Role for interleukin-1β in Trypanosoma cruzi-induced cardiac myocyte hypertrophy. Infect. Immun. 71:4441-4447.
35. Petkova, S. B., H. Huang, S. M. Factor, R. G. Pestell, B. Bouzahzah, L. A. Jelicks, L. M. Weiss, S. A. Douglas, M. Wittner, and H. B. Tanowitz. 2001. The role of endothelin in the pathogenesis of Chagas' disease. Int. J. Parasitol. 31:499-511.
36. Petkova, S. B., H. B. Tanowitz, H. I. Magazine, S. M. Factor, J. Chan, R. G. Pestell, B. Bouzahzah, S. A. Douglas, V. Shtutin, S. A. Morris, E. Tsang, L. M. Weiss, G. J. Christ, M. Wittner, and H. B. Tanowitz. 2000. Myocardial expression of endothelin-1 in murine Trypanosoma cruzi infection. Cardiovasc. Pathol. 9:257-265.
37. Ramires, F. J. A., V. L. Nunes, F. Fernandes, C. Madi, and J. A. F. Ramires. 2003. Endothelins and myocardial fibrosis. J. Cardiac Failure 9:232-237.
38. Rodeheffer, R. J., A. Lerman, D. M. Heublein, and J. C. Burnett, Jr. 1992. Increased plasma concentrations of endothelin in congestive heart failure in humans. Mayo Clin. Proc. 67:719-724.
39. Sahn, D. J., A. DeMaria, J. Kisslo, and A. Weyman. 1978. Recommendations regarding quantitation in M-mode echocardiography: results of survey of echocardiographic measurements. Circulation 58:1072-1083.
40. Sakai, S., T. Miyauchi, M. Kobayashi, I. Yamaguchi, K. Goto, and Y. Sugishita. 1998. Altered expression of isoforms of myosin heavy chain mRNA in the failing rat heart is ameliorated by chronic treatment with an endothelin receptor antagonist. J. Cardiovasc. Pharmacol. 31(Suppl. 1):S302-S305.
41. Sakai, S., T. Miyauchi, and I. Yamaguchi. 2000. Long-term endothelin receptor antagonist administration improves alterations in expression of various cardiac genes in failing myocardium rats with heart failure. Circulation 101:2849-2853.
42. Salomone, O. A., T. F. Caeiro, R. J. Madoery, M. Amichastegui, D. Juri, and J. C. Kask. 2001. High plasma immunoreactive endothelin levels in patients with Chagas' cardiomyopathy. Am. J. Cardiol. 87:1217-1220.
43. Satoshi, S., T. Miyauchi, M. Kobayashi, I. Yamaguchi, K. Goto, and Y. Sugishita. 1996. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 384:353-355.
44. Schiller, N. B., P. M. Shah, M. Crawford, A. DeMaria, R. Devereux, H. Feigenbaum, H. Gutgesell, N. Reichek, D. J. Sahn, I. Schnittger, et al. 1989. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J. Am. Soc. Echocardio. 2:358-367.
45. Sessa, W. C., S. Kaw, M. Hecker, and J. R. Vane. 1991. The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes. Biochem. Biophys. Res. Commun. 174:613-618.
46. Shohet, R. V., Y. Y. Kisanuki, X. S. Zhao, Z. Siddiquee, F. Franco, and M. Yanagisawa. 2004. Mice with cardiomyocyte-specific disruption of the endothelin-1 gene are resistant to hyperthyroid cardiac hypertrophy. Proc. Natl. Acad. Sci. USA 101:2088-2093.
47. Suhden, P. H. 2003. An over view of endothelin signaling in the cardiac myocyte J. Mol. Cell Cardiol. 35:871-886.
48. Suzuki, E., D. Nagata, M. Kakoki, H. Hayakawa, A. Goto, M. Omata, and Y. Hirata. 1999. Molecular mechanisms of endothelin-1-induced cell-cycle progression. Circ. Res. 84:611-619.
49. Tanowitz, H. B., D. K. Kaul, B. Chen, S. A. Morris, S. M. Factor, L. M. Weiss, and M. Wittner. 1996. Compromised microcirculation in acute Trypanosoma cruzi infection. J. Parasitol. 82:124-130.
50. Tanowitz, H. B., J. P. Gumprecht, D. Spurr, T. M. Calderon, M. C. Ventura, C. Raventos-Suarez, S. M. Factor, V. Hatcher, M. Wittner, and J. W. Berman. 1992. Cytokine gene expression of endothelial cells infected with Trypanosoma cruzi. J. Infect. Dis. 166:598-603.
51. Tanowitz, H. B., L. V. Kirchhoff, D. Simon, S. A. Morris, L. M. Weiss, and M. Wittner. 1992. Chagas' disease. Clin. Microbiol. Rev. 4:400-419.
52. Tanowitz, H. B., M. Wittner, S. A. Morris, W. Zhao, L. M. Weiss, V. B. Hatcher, V. L. Braunstein, H. Huang, S. A. Douglas, M. Valcic, M. Spektor, and G. J. Christ. 1999. The putative mechanistic basis for the modulatory role of endothelin-1 in the altered vascular tone induced by Trypanosoma cruzi. Endothelium 6:217-230.
53. Tarleton, R. L. 2001. Parasite persistence in the etiology of Chagas disease. Int. J. Parasitol. 31:550-554.
54. Vaidian, A. K., L. M. Weiss, and H. B. Tanowitz. 2004. Chagas' disease and AIDS. Kinetoplastid Biol. Dis. 3:2.
55. Von Lueder, T. G., H. Kjekshus, T. Edvardsen, E. Oie, S. Urheim, L. F. Vinge, M. S. Ahmed, O. A. Smiseth, and H. Attramadal. 2004. 2004. Mechanisms of elevated plasma endothelin-1 in CHF: congestion increases pulmonary synthesis and secretion of endothelin-1. Cardiovasc. Res. 63:41-50.
56. Wang, X., S. A. Douglas, C. Louden, L. M. Vickery-Clark, G. Z. Feuerstein, and E. H. Ohlstein. 1996. Expression of endothelin-1, endothelin-2, endothelin-3, endothelin converting enzyme-1, and endothelin-A and endothelin B receptor mRNA following angioplasty-induced neointimal formation in the rat. Circ. Res. 78:322-328.
57. Wittner, M., G. J. Christ, H. Huang, L. M. Weiss, V. B. Hatcher, S. A. Morris, G. A. Orr, J. W. Berman, G. A. Zeballos, S. A. Douglas, and H. B. Tanowitz. 1995. Trypanosoma cruzi induces endothelin release from endothelial cells. J. Infect. Dis. 171:493-497.
58. Yanagisawa, H., R. E. Hammer, J. A. Richardson, S. C. Williams, D. E. Clouthier, and M. Yanagisawa. 1998. Role of endothelin-1/endothelin-A receptor-mediated signaling pathway in the aortic arch patterning in mice. J. Clin. Investig. 102:22-33.
59. Yanagisawa, M. H. Kurihara, S. Kinura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. 1998. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415.
60. Yanagisawa, H., M. Yanagisawa, R. P. Kapur, J. A. Richardson, S. C. Williams, S. C., D. E. Clouthier, D. de Wit, N. Emoto and R. E. Hammer. 1998. Dual genetic pathways of endothelin-mediated intracellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene. Development 125:825-836.
61. Yang, L. L., R. Gros, M. G. Kabir, A. Sadi, A. I. Gottleib, M. Husain, and D. J. Stewart. 2004. 2004. Conditional cardiac overexpression of endothelin-1 induces inflammation and dilated cardiomyopathy. Circulation 109: 255-261.
62. Zhao, X.-S., W. Pan, R. Bekeredijian, and R. V. Shohet. 2003. Cardiac specific deletion of endothelin-1 leads to dilated cardiomyopathy, abstr. 722. Circulation 108:17; IV-153.